SIMCERE PHARMAC. GRP LTD Financial Flexibility Index
SIMCERE PHARMAC. GRP LTD financial flexibility index. SIMCERE PHARMAC. GRP LTD (S2P) has a Financial Flexibility Index of 0.54x as of December 2025. Free cash flow of €2.88 Billion (operating CF €2.01 Billion minus capex €862.20 Million) represents 1% of total liabilities (€5.31 Billion). See free cash flow generation of SIMCERE PHARMAC. GRP LTD to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of SIMCERE PHARMAC. GRP LTD (2021–2025)
Financial flexibility index of SIMCERE PHARMAC. GRP LTD from 2021 to 2025. Historical Financial Flexibility Index trend for SIMCERE PHARMAC. GRP LTD across 5 annual periods. Check how high is SIMCERE PHARMAC. GRP LTD's earnings quality to evaluate the quality of earnings relative to operating cash generation.
SIMCERE PHARMAC. GRP LTD Financial Flexibility Index by Year (2021–2025)
SIMCERE PHARMAC. GRP LTD financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for SIMCERE PHARMAC. GRP LTD. For the full cash flow conversion analysis, see SIMCERE PHARMAC. GRP LTD cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.54x | €2.88 Billion | €2.01 Billion | €5.31 Billion | ▲ +11.7% |
| 2024 | 0.48x | €2.15 Billion | €1.39 Billion | €4.44 Billion | ▲ +55.7% |
| 2023 | 0.31x | €1.13 Billion | €151.05 Million | €3.63 Billion | ▼ -44.2% |
| 2022 | 0.56x | €2.03 Billion | €1.35 Billion | €3.64 Billion | ▲ +27354.5% |
| 2021 | 0.00x | €7.52 Million | €-201.97 Million | €3.70 Billion | — |